Adipose tissue-derived mesenchymal stem cells cultured at high cell density express brain-derived neurotrophic factor and exert neuroprotective effects in a 6-hydroxydopamine rat model of Parkinson’s disease

Genes and Genomics

Volumn 37, Issue 2, 2015, Pages 213-221

  Park, Joon Beom ^a   Lee, Jin Suk ^a   Cho, Byung Pil ^a   Rhee, Ki Jong ^b   Baik, Soon Koo ^a   Kim, Jiye ^a   Kang, Seong Joon ^a   Park, Dong Joon ^a   Oh, Ji Eun ^a   Shin, Ha Cheol ^c   Kim, Yong Man ^c   Kim, Hyun Soo ^c   Bae, Keum Seok ^a   Eom, Young Woo ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Pharmicell Co Ltd   (South Korea)

Author keywords

Adipose tissue derived mesenchymal stem cells; Brain derived neurotrophic factor; Neuroprotection; Parkinson s disease

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLINE; NERVE GROWTH FACTOR; OXIDOPAMINE; PROTEIN KINASE B; TYROSINE 3 MONOOXYGENASE;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL DENSITY; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CISTERNA MAGNA; COCULTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL PARKINSONISM; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; STEM CELL CULTURE; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84925543438     PISSN: 19769571     EISSN: 20929293     Source Type: Journal    
DOI: 10.1007/s13258-014-0239-0     Document Type: Article

References (34)

1. Ambjorn M, Ejlerskov P, Liu Y, Lees M, Jaattela M, Issazadeh-Navikas S (2013) IFNB1/interferon-beta-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function. Autophagy 9:287–302
2. Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A (2009) Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism. J Neuroimmunol 211:114–119
3. Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A (2005) Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Arch Neurol 62:563–568
4. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR (2007) Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6:975–990
5. Bouchez G, Sensebe L, Vourc’h P, Garreau G, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S (2008) Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson’s disease. Neurochem Int 52:1332–1342
6. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402
7. Chen X, Katakowski M, Li Y, Lu D, Wang L, Zhang L, Chen J, Xu Y, Gautam S, Mahmood A, Chopp M (2002) Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69:687–691
8. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174:101–109
9. Dormady SP, Bashayan O, Dougherty R, Zhang XM, Basch RS (2001) Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res 10:125–140
10. Geeta R, Ramnath RL, Rao HS, Chandra V (2008) One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem Biophys Res Commun 373:258–264
11. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Vinuela A, Kim KS, Isacson O (2008) Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson’s disease. Stem Cells 26:1526–1536
12. Hornykiewicz O (1973) Parkinson’s disease: from brain homogenate to treatment. Fed Proc 32:183–190
13. Huang H, Xiao T, He L, Ji H, Liu XY (2012) Interferon-beta-armed oncolytic adenovirus induces both apoptosis and necroptosis in cancer cells. Acta Biochim Biophys Sin 44:737–745
14. Ibanez CF (1994) Structure-function relationships in the neurotrophin family. J Neurobiol 25:1349–1361
15. Isacson O (2003) The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol 2:417–424
16. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49
17. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A (2007) Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res 1179:140–146
18. Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, Jiang CC (2003) Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 21:190–199
19. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D (2008) Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson’s disease. Cytotherapy 10:340–352
20. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 102:18171–18176
21. Muraoka K, Shingo T, Yasuhara T, Kameda M, Yuen WJ, Uozumi T, Matsui T, Miyoshi Y, Date I (2008) Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease. J Neurosurg 108:149–159
22. Murrell W, Wetzig A, Donnellan M, Feron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A (2008) Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson’s disease. Stem Cells 26:2183–2192
23. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2005) I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136:161–169
24. O’Keeffe FE, Scott SA, Tyers P, O’Keeffe GW, Dalley JW, Zufferey R, Caldwell MA (2008) Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson’s disease. Brain 131:630–641
25. Pakkenberg B, Moller A, Gundersen HJ, Mouritzen Dam A, Pakkenberg H (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson’s disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54:30–33
26. Park HJ, Lee PH, Bang OY, Lee G, Ahn YH (2008) Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease. J Neurochem 107:141–151
27. Pestka S (2007) The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 282:20047–20051
28. Ryu H, Oh JE, Rhee KJ, Baik SK, Kim J, Kang SJ, Sohn JH, Choi E, Shin HC, Kim YM, Kim HS, Bae KS, Eom YW (2014) Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and suppress the growth of MCF-7 human breast cancer cells. Cancer Lett 352:220–227
29. Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Ilan AB, Bulvik S, Shemesh N, Krepel D, Cohen Y, Melamed E, Offen D (2009) Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev 18:1179–1190
30. Schabitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31:2212–2217
31. Sensebe L, Deschaseaux M, Li J, Herve P, Charbord P (1997) The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment. Stem Cells 15:133–143
32. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307–336
33. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci USA 105:5856–5861
34. Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M (2007) Interferon-beta therapy reduces CD4 + and CD8 + T-cell reactivity in multiple sclerosis. Immunology 121:29–39